What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Discover proven strategies to grow small investments. Learn how to make the most of your financial resources effectively.
19,213 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
CoStar Group appoints Robin Rossmann as chief financial officer, effective July 31, 2026, succeeding Christian Lown. ...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
ServiceNow is set to report Q2 results after the close as investors weigh growth, margins, and AI monetization progre...
Capital gains taxes can impact your investment returns. This guide explains how gains from stocks and real estate are...
The Dow climbs while CRM, MSFT, and UNH slip, signaling a split market in 2026. This piece explains why the dow’s big...
This in-depth guide breaks down Employers EIG 2025 earnings, focusing on Q4 results, guidance, and what it means for ...
Astronics faces a pivotal year as 2025 earnings unfold. This guide breaks down the drivers, risks, and actionable ste...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
Markets are betting that rates will edge lower this year, nudging investors toward income-focused and rate-sensitive ...